Veristat clinical trial project teams help our clients reach their clinical trial milestones and achieve success every day.We work collaboratively with clinical trial sites starting with feasibility and site initiation activities and continue this collaborative approach throughout the lifetime of the clinical study. We engage early with the study site coordinators and investigators to establish relationships where recruitment challenges can be discussed openly and solutions can be implemented working together in partnership with the site. Having many years of experience assisting sites with rare disease and complicated therapeutic area clinical studies, our teams are experts at helping sites achieve their recruitment goals.
Read about recent clinical trial successes that we’ve shared with a few of our clients so far this year.
ACHIEVED FIRST PATIENT ENROLLED MILESTONE FOR OVARIAN CANCER IMMUNOTHERAPY
Veristat is currently managing and monitoring a Phase I/2 Study for patients with recurrent ovarian cancer and our client just announced its first patient enrolled milestone was achieved. Read about this clinical program with OncoQuest.
ESTABLISHED PREFERRED PARTNERSHIP AFTER BEATING AN ENROLLMENT TIMELINE
Veristat secures a Preferred Provider Agreement (PPA) with AOBiome to provide ongoing and future clinical research services including strategic consulting, clinical monitoring, clinical data management, biostatistical analysis, SAS programming, clinical protocol and study report writing, project management, and preparation of materials for submission to regulatory authorities.
"We are very happy with the progress that the Veristat team has made on our phase II study in hypertension, having met the enrollment timelines earlier than planned,” said Todd Krueger, President of AOBiome. “I’m impressed with the strength and breadth of therapeutic experience of their team and value their dedication to our success, transparent communications, and expert management of the hypertension study. Under the PPA, we plan to partner with Veristat to launch additional clinical trials in indications where we think that our bacterial platform will provide novel treatment options to patients.”
To learn more about this engagement, read the full press release:
CONTACT VERISTAT TO BECOME ONE OF OUR SUCCESS STORIES
These are just a few of the remarkable clinical trial success stories that we shared with our clients this year. Contact us today to hear more of our successes and learn how we can put our clinical trial and regulatory submission experts to work for you. We want to help you achieve success!